(Q46793170)

25 December 2017

editorial

0 references

title

The power in numbers: gut microbiota in Parkinson's disease (English)

1 reference

25 December 2017

1 reference

Joaquin A Vizcarra

1

0 references

author name string

Hilary E Wilson-Perez

series ordinal

2

1 reference

25 December 2017

Alberto J Espay

series ordinal

3

1 reference

25 December 2017

language of work or name

English

0 references

publication date

27 December 2014

1 reference

25 December 2017

published in

Movement Disorders

1 reference

25 December 2017

volume

30

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

296-298

1 reference

25 December 2017

Prokaryotes: the unseen majority

cites work

1 reference

The NIH Human Microbiome Project

21 January 2018

1 reference

Inflammatory bowel disease as a model for translating the microbiome

21 January 2018

1 reference

Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission

21 January 2018

1 reference

Compositional and functional features of the gastrointestinal microbiome and their effects on human health

21 January 2018

1 reference

Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.

21 January 2018

1 reference

Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease

21 January 2018

1 reference

Enterotypes of the human gut microbiome

21 January 2018

1 reference

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States

21 January 2018

1 reference

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.

21 January 2018

1 reference

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

21 January 2018

1 reference

Modeling Lewy pathology propagation in Parkinson's disease

21 January 2018

1 reference

The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis

21 January 2018

1 reference

Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease

21 January 2018

1 reference

Endotoxin: is it an environmental factor in the cause of Parkinson's disease?

21 January 2018

1 reference

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

21 January 2018

1 reference

Colonic inflammation in Parkinson's disease.

21 January 2018

1 reference

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

21 January 2018

1 reference

A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders

21 January 2018

1 reference

Structural and functional characterization of two alpha-synuclein strains

21 January 2018

1 reference

Fusobacterium and Enterobacteriaceae: important players for CRC?

21 January 2018

1 reference

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.26116

1 reference

25 December 2017

PubMed ID

25545262

1 reference

25 December 2017